Fulgent Genetics, Inc. (FLGT)

Fulgent Genetics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	87.88	55.14	97.47	79.51	164.89	87.43
Short-Term Investments	205.05	202.96	326.68	446.73	285.61	211.94
Cash & Short-Term Investments	292.93	258.11	424.15	526.24	450.5	299.37
Cash Growth	-6.02%	-39.15%	-19.40%	16.81%	50.48%	958.99%
Accounts Receivable	77.19	69.02	51.13	52.75	139.15	185.24
Other Receivables	7.85	8.01	6.31	22.36	4.15	18.83
Receivables	85.04	77.03	57.45	75.11	143.3	204.06
Prepaid Expenses	5.33	6.63	7.74	6.81	4.24	3.68
Other Current Assets	45.44	11.81	18.5	19.71	13.92	16.51
Total Current Assets	428.73	353.57	507.85	627.87	611.96	523.62
Property, Plant & Equipment	115.54	111.72	95.62	98.92	71.16	41.03
Long-Term Investments	499.47	595.28	444.01	339.03	507.01	132.5
Goodwill	22.06	22.06	22.06	143.03	50.9	-
Other Intangible Assets	131.06	134.98	143.05	150.64	35.91	-
Long-Term Deferred Tax Assets	-	-	-	3.5	0.76	1.63
Other Long-Term Assets	2.98	2.37	22.75	23.05	1.02	1.69
Total Assets	1,200	1,220	1,235	1,386	1,279	700.46
Accounts Payable	18.89	18.36	15.36	23.09	20.49	26.39
Accrued Expenses	20.16	22.44	26.24	17.91	15.52	8.54
Short-Term Debt	-	-	-	15	21.28	15.02
Current Portion of Long-Term Debt	0.48	0.41	1.18	5.64	-	-
Current Portion of Leases	1.54	1.84	4.5	7.08	2.17	-
Current Income Taxes Payable	-	-	-	-	0.79	53.32
Current Unearned Revenue	2.67	2.23	2.87	3.2	14.57	26.58
Other Current Liabilities	27.6	27.61	22.86	16.2	30.49	0.27
Total Current Liabilities	71.34	72.9	73.02	88.11	105.31	130.12
Long-Term Debt	1.96	2.49	2.96	-	-	-
Long-Term Leases	3.95	4.48	7.91	10.61	6.74	0.57
Long-Term Deferred Tax Liabilities	6.12	6.37	7.96	-	-	-
Other Long-Term Liabilities	4.84	4.56	10.19	17.46	0.79	0.39
Total Liabilities	88.2	90.81	102.04	116.18	112.84	131.07
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	550.6	543.13	501.72	486.59	501.91	418.07
Retained Earnings	559.98	590.47	633.18	801	657.6	150.88
Comprehensive Income & Other	6	-0.37	1.21	-20.9	-0.76	0.44
Total Common Equity	1,117	1,133	1,136	1,267	1,159	569.39
Minority Interest	-4.94	-4.07	-2.82	3.19	7.13	-
Shareholders' Equity	1,112	1,129	1,133	1,270	1,166	569.39
Total Liabilities & Equity	1,200	1,220	1,235	1,386	1,279	700.46
Total Debt	7.92	9.23	16.56	38.33	30.2	15.59
Net Cash (Debt)	769.48	819.23	831.17	814.56	905.35	416.28
Net Cash Growth	-6.67%	-1.44%	2.04%	-10.03%	117.48%	516.35%
Net Cash Per Share	25.14	27.10	27.91	26.31	29.23	17.30
Filing Date Shares Outstanding	30.61	30.83	29.78	29.52	30.25	28.87
Total Common Shares Outstanding	30.61	30.84	29.65	29.44	30.16	28.18
Working Capital	357.39	280.67	434.83	539.77	506.65	393.5
Book Value Per Share	36.48	36.74	38.31	43.03	38.42	20.21
Tangible Book Value	963.47	976.2	970.99	973.02	1,072	569.39
Tangible Book Value Per Share	31.48	31.65	32.75	33.05	35.54	20.21
Land	17.35	17.35	8.8	7.5	7.5	7.5
Buildings	49.68	49.61	17.53	12.6	10.67	7.44
Machinery	82.59	76.07	73.65	71.97	51.22	31.6
Leasehold Improvements	4.32	3.32	11.22	11.8	4	1.58

Updated Aug 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q